What Are The Symptoms and Diagnosis of Lymphoma In The Lungs?

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system. When lymphoma begins in the lungs, it is called primary pulmonary lymphoma (PPL).

Lymphoma in the Lungs Symptoms and Diagnosis

More often than not, lymphoma in the lungs causes no discernable symptoms and is found incidentally when a chest X-ray shows an anomaly. When a person with Non Hodgkin's Lymphoma in the lungs, whether primary or secondary, does have symptoms, they might include:

    Fevers
  • Unexplained weight loss
  • Chest pain
  • An unexplained cough
  • Hemoptysis (coughing up a little blood)
  • Dyspnea (shortness of breath)

Lymphoma in the Lungs Treatment and Prognosis

Typical treatment for lymphoma in the lungs is to hit it with combination, doxorubicin and Rituxan-based chemotherapy—namely R-CHOP. However, the optimal treatment for lymphoma in the lungs has not been determined, most likely because the lung disease is so rare. Lymphoma in the lungs can be either indolent or aggressive, but it is more commonly an indolent disease, and therefore the median survival times for these patients between 8 and 10 years.

Click here for a more detailed look at primary pulmonary lymphoma.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap